Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting

Tysabri® Observational Program (TOP) Investigators, Veronique Bissay

Onderzoeksoutput: Article

11 Citaten (Scopus)

Vingerafdruk

Duik in de onderzoeksthema's van 'Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting'. Samen vormen ze een unieke vingerafdruk.

Medicine & Life Sciences